When we add the cost of running the screening programme to the expense of treating the condition, the overall cost for the management of DDH is comparable for the different screening policies. [Br] 1999;81-B:852-7. 
The traditional method of routine screening for the early diagnosis of developmental dysplasia of the hip (DDH) in the UK and elsewhere in Europe and North America has been by clinical examination. The method favoured for the detection of dislocation has been the technique described by Ortolani, 1 and for subluxation that of Barlow. 2 These tests were first described by Le Damany 3 at the turn of the century. The adoption of these methods to identify all infants with abnormality of the hips has not been universally successful, and has failed to eliminate late presentations of subluxation and dislocation for a number of infants who present with an established abnormality. [4] [5] [6] Such late presentation frequently results in the need for major operations 7 which often have an unsatisfactory long-term outcome with the development of early degenerative changes in the hip and functional morbidity. The pioneering work in ultrasound examination of Graf 8 in Austria and Harcke et al 9 in the USA has revolutionised our understanding of the process of the disease and allowed the identification and early treatment of instability of the hip. The success of a routine screening programme in Austria and more recently in Germany has stimulated interest elsewhere. We reported the success of our routine ultrasound screening programme in 1994. 10 The introduction of such a programme in the UK, and no doubt elsewhere in Europe, usually requires a business plan since the financial implications of any new development may affect its adoption or rejection. To date, there have been few published data on the financial implications and possible benefits of this type of programme. This lack of information stimulated us to investigate the financial implications in the light of the changes in our practice since 1976.
Patients and Methods
Between 1976 and 1986 (group A) we followed a routine programme of clinical screening for DDH. This had a rate of late presentation for subluxation and dislocation of about 41% for all infants born in Coventry. These infants had been examined at birth by a paediatrician. After discharge from hospital further examination was carried out by a community physician or general practitioner. Those with a suspected hip abnormality, or who fell within the recognised 'at-risk' groups, were seen for review in the weekly Orthopaedic Baby Clinic. In 1986 we introduced ultrasonographic assessment of the hip in addition to clinical examination for all infants within the 'at-risk' categories and those with a clinical abnormality of the hip (group B). This system could not identify those infants who did not have 'at-risk' factors and whose abnormal hip was not identified at birth by paediatricians. Some dislocations therefore presented late which resulted in a number of operations and additional costs of treatment.
In June 1989 we were able to introduce a routine ultrasound screening service for all infants born within the Coventry area (group C), either in a hospital maternity unit (over 98%), at home, or elsewhere. This was in addition to the statutory clinical examination. All infants have a routine ultrasound scan by trained radiographers according to the techniques described by Harcke et al 9 By identifying all patients who had surgery for DDH between 1976 and 1996 from operating-theatre records and the personal records of the senior author, we have been able to compare the costs of surgical intervention for the three different methods of screening.
The patients were grouped according to their year of birth, irrespective of the actual date of their presentation to the paediatric orthopaedic department or the timing of surgery. Hence all the costs of surgical treatment incurred by a particular child for the management of his/her hip during the subsequent years were included in the costs for the year in which the child was born.
We have excluded children born outside the Coventry area and those with teratological dislocations or coexisting pathology such as cerebral palsy, which could alter the progression of the disorder. All other cases have been included.
All costs were estimated at present-day prices and included procedures assessed in terms of units of operating theatre time, consumables such as implants and blood, and radiological expenses. Information was obtained from the various directorates involved. Hospital admission. This was calculated at £200 per day (including fixed costs). The duration of admission to the hospital was standardised in accordance with the procedure which was performed. Conservative figures for the length of hospital stay were used and hence the actual costs for admission may be slightly higher than shown. All patients having primary open surgery on the hip were admitted for a preoperative period of traction in hospital for two weeks and the duration of stay in hospital was for a minimum of 18 days. Children who had isolated pelvic or femoral osteotomies were in hospital for a minimum of four days. Arthrography, adductor tenotomies and application of plaster spicas were classified as day-case procedures and inpatient costs were calculated as nil. Costs of the operating theatre and surgical team. Time in the operating theatre was costed at £106 per hour, i.e., £26.50 per 15 minutes, and that of the surgical team (consultant anaesthetist, consultant surgeon and registrar) at £17.50 per 15 minutes. Thus the total theatre cost was £44 per 15 minutes. The procedures are timed as shown in Table I . Surgical implant. For femoral osteotomies we used the Coventry screw and plate which cost £100. Radiological services and the cost of contrast material. The radiology department estimated the staff time, use of the image intensifier and the x-ray plate as £20 for a pelvic osteotomy, £40 for a femoral osteotomy and £60 for arthrography. The cost of contrast material (Niapam) was £23.62 per vial. Blood. One unit of blood cost £36. We assumed that one unit would be cross-matched for every patient who had a femoral or pelvic osteotomy. The total amount for each patient was finally rounded off to the nearest pound.
The cost of non-operative treatment in a Pavlik harness is £37. These infants are reviewed on a weekly basis in the clinic.
The use of ultrasonographers and equipment for one screening session per week in the outpatient clinic incurs a cost of £4000 per year. Routine screening of all infants requires six sessions per week of an ultrasonographer's time with a total expenditure of £24 000; 'at-risk' screening utilises one session per week. 
Results
Between January 1976 and December 1996, 103 children required a total of 254 separate theatre sessions with a total surgical cost of £298 053. The details of the cost in each year are given in Table II .
Since the introduction of routine screening (group C) the incidence of abnormality in first scans has been 7.3%. Infants in this category were reviewed at two to three weeks. The rate decreases to 0.4% by six weeks, which equates to 129 patients in the 7.5-year period up until the end of 1996. In all but 19 patients (0.06% of the total) subsequent treatment in a Pavlik harness was successful. After an arthrogram, 17 of these infants were managed by closed reduction. Two required major open surgery.
The average annual cost of treatment in group A was £5110 per 1000 live births. This compares with £3811 per 1000 live births in group B and £468 per 1000 live births in group C. The birth rate was relatively steady throughout the study period at around 4000 live births per year.
Analysis of the case load per year in each of the groups (Fig. 1) shows that the mean number of patients treated surgically has declined progressively from 6.5 (group A) to 5.4 (group B) and 2.5 (group C). In addition, the number of theatre sessions per case has fallen from 2.8 to 2.1 and then to 1.8 in groups A, B and C, respectively.
When the operated cases are divided into major procedures (open reduction of hip, femoral and pelvic osteotomies) and day-case procedures (arthrography, adductor tenotomy, application of spica) there has been a strong trend towards less invasive surgery since the introduction of routine ultrasound screening (Fig. 2) . The percentage of procedures requiring hospital admission was 47% in group A, 61% in group B and 9% in group C. Only two major procedures were performed in the 7.5 years from June 1989 to December 1996. There were no late presentations of dislocated or subluxed hips in this period.
Since the introduction of routine ultrasound screening both the mean age at which surgery is first performed and the mean age of all surgery for each child has decreased (Fig. 3) . If one considers the three groups independently the mean age at the time of the first operation was 12.4 months, 14.2 months and 6.7 months in groups A, B and C, respectively. Fig. 1 Analysis of the case load per year in each of the groups. Number of cases of inpatient surgery and day-care in each of the groups. Figure 4 shows the contribution of treatment in a harness to overall costs along with the expenses incurred by screening. The final overall cost for group A was £22 188 per year, for group B £21 837 and for group C £26 564.
Discussion
The basis of the economic success of ultrasound screening is the established finding that if DDH is identified early then it can be treated conservatively by gentle abduction of the hips by a simple brace. [11] [12] [13] If the diagnosis is delayed the infant will usually require surgical treatment. 7, 14 We have shown that with the introduction of routine ultrasound screening we have significantly decreased the number of children requiring operation for DDH, and those who need surgery are operated on at an earlier stage, have less extensive procedures and fewer total operations. The benefits gained by screening 'at-risk' infants in each of these categories were modest when compared with those of clinical screening, and routine screening of all infants was significantly superior to both of the other methods. Clinical screening fails to diagnose abnormality in a considerable proportion of cases of DDH. 15, 16 While there have been a number of reports of high rates of detection, 17, 18 we have previously calculated our rate of failure to be 50% using clinical examination alone. 6 This matches other studies 16, 19 including that of Palmén 19 who reviewed 98 000 live births in Sweden in 1976. In this series, which is one of the largest published, the rate of failure decreased to 15% by seven months which was then too late to initiate treatment in a Pavlik harness. Only 40% of infants with a clinically detectable abnormality of the hip have 'at-risk' signs. 6, 20 A prerequisite for any screening programme is that it be highly sensitive, with low false-negatives. In Coventry we have had no cases of late-presenting DDH since the introduction of routine screening. Furthermore, despite rigorous searching, we have been unable to identify any infants born in Coventry who have been referred to other centres in the UK. The success of early treatment with the Pavlik harness is shown by the finding that of the 32 384 infants scanned between June 1989 and December 1996 only two (0.006%) required major surgery, both having open reduction after failure of conservative treatment. There must be a high rate of compliance for screening. By scanning infants before they leave hospital we have managed to examine 98% of all the infants born in Coventry. Scanning at four to six weeks has been shown to The mean age at surgery and the mean age at first operation throughout the study period. have a non-attendance rate of nearly 30%. 20 We accept that by scanning at birth we are identifying a number of 'physiologically immature' hips which will resolve spontaneously. Tschauner, Klapsch and Graf 21 have suggested that the greatest potential for remodelling of the hip is in the first three months of life and they advocate routine screening at birth with immediate treatment since they consider that cases of types III and IV will not resolve spontaneously. In Austria this regime has been shown to be cost-effective and to have reduced rates of operative intervention. 22, 23 The trend towards earlier treatment has also been advocated by Harding et al, 13 who have shown increased efficacy when use of a Pavlik harness is begun within the first three months of life. In our series 7.3% of first scans showed some abnormality which is the same as that reported by Hensinger, 24 but only 0.4% of such infants required treatment for persistent abnormality. This is comparable with the 0.39% reported in a selectively screened population in Sheffield, 25 and the 0.37% reported by the senior author (JC) in Coventry before the introduction of routine ultrasound screening. This would appear to negate the criticism that routine screening leads to increased rates of intervention and an increased risk of avascular necrosis by splinting hips in abduction. The incidence of this complication has been quoted as being between 0% and 22%, 25, 26 but by close supervision and weekly review using ultrasound it has not so far occurred in our series. All children with abnormal scans are followed at least until walking age when plain radiography is performed. On the basis of persistent ultrasonic abnormality in the absence of subluxation or dislocation 69 infants were treated by Pavlik harness. By contrast, some infants with a clinical abnormality at birth were followed ultrasonically and showed steady improvement so that treatment was not necessary. This is the group described by Barlow 2 as
showing a return to stability without treatment in the first few weeks of life. Since the technique was only described in 1980, the natural history of ultrasonographically abnormal but clinically normal hips has not yet been fully elucidated. It has been suggested that some hips with acetabular dysplasia are stable at birth but become progressively more unstable with time. [27] [28] [29] This may be one end of a spectrum, while at the other end are those infants with ultrasonic evidence of acetabular dysplasia who never progress to instability but are prone to the early development of osteoarthritis. It has been shown that this complication is more likely to occur in subluxated rather than dislocated hips because of the higher areas of contact between the femoral head and acetabulum. 29 Between 25% and 40% of patients with early-onset osteoarthritis have signs of previous acetabular dysplasia. 30, 31 The benefits in terms of the saving of costs for the health service and quality of life of the patient would be considerable if treatment in childhood could prevent development of dysplasia and subsequent arthritis. As yet there is no evidence to support the theory that treatment of clinically normal but ultrasonographically dysplastic hips would alter this progression. Observation of patients treated before the advent of ultrasound and therefore with clinically unstable hips, however, have shown that the earlier treatment is begun the less likely is the eventual development of degenerative disease. 32 The total cost of screening for our hospital is £24 000 per year. With a live birth rate of approximately 4000 per year, the cost of screening of each child is £6. This compares very favourably with other centres. 19, 33 Our figures are based on the actual number and types of operation performed on each child with DDH after presentation and not on an assumption of the incidence of the problem in the region as was done by Tredwell 33 and Fulton and Barer. 34 Their figures were based on the Canadian health service and cost structure. We also differ in that trained ultrasonographers rather than medical personnel perform the routine scanning. Each scan is personally reviewed by the senior author. The costs incurred by treating infants in a Pavlik harness contribute little to the overall expenditure. Since 1989 the costs of surgery have been reduced since most procedures are performed as day cases.
The overall cost of management of DDH in Coventry has increased marginally since the introduction of routine ultrasound scanning. This does not take into account the potential long-term savings of costs which would occur by the reduction in the risk of developing arthritis secondary to acetabular dysplasia or the costs of litigation from missed cases. 35 It is to be hoped that the quality of life for those infants who have benefited from our programme of early detection and more conservative treatment will be greatly improved, but it is difficult to put a price on this functional benefit.
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